WHO ICTRP trial
A 4-WEEK STUDY OF DOUBLE-BLIND PARALLEL GROUPS TO EVALUATE THE SAFETY AND…
PER-048-04 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-048-04 |
|---|---|
| Public title | A 4-WEEK STUDY OF DOUBLE-BLIND PARALLEL GROUPS TO EVALUATE THE SAFETY AND EFFICACY OF 60 MG ETORICOXIB AND 150MG DICLOFENACO IN PATIENTS WITH CHRONIC LUMBALGIA. |
| Scientific title | A 4-WEEK STUDY OF DOUBLE-BLIND PARALLEL GROUPS TO EVALUATE THE SAFETY AND EFFICACY OF 60 MG ETORICOXIB AND 150MG DICLOFENACO IN PATIENTS WITH CHRONIC LUMBALGIA. |
| Primary sponsor | MERCK SHARP & DOHME PERU S.R.L., |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | IV |
| Countries | Peru;United States |
| Conditions | -M545 Low back pain Low back pain;M545;Low back pain |
| Interventions | Group name:Etoricoxib 60 mg Type of group;1 N° of participants:200 Intervention(s) description:Etoricoxib 60 mg is administered orally for 4 weeks in patients with chronic low back pain. Group name:Diclofenac 150 mg Type of group;2 N° of… |
| Registration date | Jun 7, 2004 |
| Target size | 32 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: